1. Become aware of novel mechanisms of actions of SGLT2 inhibitors.
2. Become aware of the changes in progression of kidney disease in diabetes.
3. Become aware of changes in guidelines and FDA labeling based on recent publications.
12/16/2019 - 5:00pm to 6:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
George L. Bakris, M.D.